EXPLORE THE UNIVERSITY OF OXFORD'S WORLD-CLASS RESEARCH

1 entry found
1
Journal article icon
Journal article

Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

  • Mesa, R, Vannucchi, A, Mead, A, et al.
  • 2017-03-20
File available icon
Peer reviewed icon
Link to publisher copy available icon
FILTER RESULTS

TO TOP